- Home
- GME vs ROIV Comparison
GME vs ROIV Comparison
Compare GME & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GME
- ROIV
- Stock Information
- Founded
- GME 1996
- ROIV 2014
- Country
- GME United States
- ROIV United Kingdom
- Employees
- GME N/A
- ROIV N/A
- Industry
- GME Electronics Distribution
- ROIV Biotechnology: Pharmaceutical Preparations
- Sector
- GME Consumer Discretionary
- ROIV Health Care
- Exchange
- GME Nasdaq
- ROIV Nasdaq
- Market Cap
- GME 10.5B
- ROIV 8.4B
- IPO Year
- GME 2002
- ROIV N/A
- Fundamental
- Price
- GME $26.77
- ROIV $11.03
- Analyst Decision
- GME Sell
- ROIV Buy
- Analyst Count
- GME 1
- ROIV 4
- Target Price
- GME $10.00
- ROIV $17.50
- AVG Volume (30 Days)
- GME 7.3M
- ROIV 6.2M
- Earning Date
- GME 06-06-2025
- ROIV 05-29-2025
- Dividend Yield
- GME N/A
- ROIV N/A
- EPS Growth
- GME 1550.00
- ROIV N/A
- EPS
- GME 0.33
- ROIV N/A
- Revenue
- GME $3,823,000,000.00
- ROIV $122,585,000.00
- Revenue This Year
- GME N/A
- ROIV N/A
- Revenue Next Year
- GME N/A
- ROIV N/A
- P/E Ratio
- GME $81.15
- ROIV N/A
- Revenue Growth
- GME N/A
- ROIV 140.04
- 52 Week Low
- GME $15.35
- ROIV $8.73
- 52 Week High
- GME $64.83
- ROIV $13.06
- Technical
- Relative Strength Index (RSI)
- GME 53.42
- ROIV 54.56
- Support Level
- GME $25.67
- ROIV $11.02
- Resistance Level
- GME $28.35
- ROIV $11.77
- Average True Range (ATR)
- GME 0.88
- ROIV 0.31
- MACD
- GME -0.18
- ROIV 0.03
- Stochastic Oscillator
- GME 40.86
- ROIV 57.95
About GME GameStop Corporation
GameStop Corp is a U.S. multichannel video game, consumer electronics, and services retailer. The company operates across Europe, Canada, Australia, and the United States. The company sells new and second-hand video game hardware, physical and digital video game software, and video game accessories, mainly through GameStop, EB Games, and Micromania stores and international e-commerce sites. The majority of sales are from the United States. The company categorizes its products in three categories: Hardware and accessories, Software, and Collectibles. The company generates the majority of its revenue from the sale of Hardware and accessories products.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.